A quinoxaline derivative as a potent chemotherapeutic agent, alone or in combination with benznidazole, against Trypanosoma cruzi.
<h4>Background</h4>Chagas' disease is a condition caused by the protozoan Trypanosoma cruzi that affects millions of people, mainly in Latin America where it is considered endemic. The chemotherapy for Chagas disease remains a problem; the standard treatment currently relies on a si...
Guardado en:
Autores principales: | Jean Henrique da Silva Rodrigues, Tânia Ueda-Nakamura, Arlene Gonçalves Corrêa, Diego Pereira Sangi, Celso Vataru Nakamura |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2c6ccb3aacc2409c8736d7700fc2247a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Effects of buthionine sulfoximine nifurtimox and benznidazole upon trypanothione and metallothionein proteins in Trypanosoma cruzi.
por: MAYA,JUAN DIEGO, et al.
Publicado: (2004) -
Protein Profiles of Trypanosoma cruzi and Trypanosoma rangeli
por: MEJÍA,ASTRID J, et al.
Publicado: (2004) -
Natural reservoirs of Trypanosoma cruzi
Publicado: (2000) -
Synthesis of Silver Nanoparticle Employing Corn Cob Xylan as a Reducing Agent with Anti-Trypanosoma cruzi Activity
por: Brito TK, et al.
Publicado: (2020) -
mRNA localization mechanisms in Trypanosoma cruzi.
por: Lysangela R Alves, et al.
Publicado: (2013)